Although use of smart technologies for self-diagnosis and care management offers patients convenience, cost-savings, and expediency, they may also contribute to poor decision-making and harm. This commentary explores the impact of direct-to-consumer monitoring devices and smartphone applications on care and the therapeutic relationship. The authors advocate for regulation and assessment regarding accuracy of these tools.